Business, energy, technology, markets and global industry news from Business News Today

Advanced Research Projects Agency for Health

PharmaDeviceNews Advanced Research Projects Agency for Health
AcroCyte Therapeutics is advancing scalable human kidney organoid research through its ARPA-H-funded RACE programme, targeting new manufacturing capabilities for regenerative medicine and bioartificial kidney development. Representative image.
Pharma & Biotech

Can AcroCyte turn a $4.3m ARPA-H award into a scalable bioartificial kidney platform?

AcroCyte’s $4.3m ARPA-H-backed RACE project targets scalable autologous kidney organoids, but manufacturing and animal data remain the key tests.

Read More
Apertura Gene Therapy’s TfR1 CapX delivery platform will support an ARPA-H-backed consortium developing gene-editing therapies for Dravet syndrome, alternating hemiplegia of childhood and other rare pediatric neurological diseases. Representative image.
Pharma & Biotech

Apertura joins $34.5m ARPA-H PERC program for rare pediatric CNS gene editing

Apertura joins Broad’s $34.5 million ARPA-H PERC program, pairing TfR1 CapX with gene editing for rare pediatric brain diseases.

Read More